TY - JOUR
T1 - Creation and assessment of a clinical predictive model for candidaemia in patients with candiduria
AU - Wang, Katie
AU - Hsueh, Kevin
AU - Kronen, Ryan
AU - Lin, Charlotte
AU - Salazar, Ana S.
AU - Powderly, William G.
AU - Spec, Andrej
N1 - Funding Information:
This study was funded by Astellas Pharma Global Development, Inc., through an investigator‐sponsored grant (MYCA‐15L03). Astellas Pharma Global Development, Inc., was not involved in study design, implementation, data analysis, manuscript drafting or the final approval for publication. This was the sole responsibility of the authors. In addition, research reported in this publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences (NCATS) and the National Cancer Institute grant T32CA190194 of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH or Astellas Pharma Inc.
Funding Information:
Funding information This study was funded by Astellas Pharma Global Development, Inc., through an investigator-sponsored grant (MYCA-15L03). Astellas Pharma Global Development, Inc., was not involved in study design, implementation, data analysis, manuscript drafting or the final approval for publication. This was the sole responsibility of the authors. In addition, research reported in this publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences (NCATS) and the National Cancer Institute grant T32CA190194 of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH or Astellas Pharma Inc. We would like to thank Cherie Hill and Dorothy Sinclair for their contribution to the patient database.
Publisher Copyright:
© 2019 Blackwell Verlag GmbH
PY - 2019/7
Y1 - 2019/7
N2 - Candidaemia is the most common clinical presentation of invasive candidiasis and is a major cause of morbidity and mortality. Candiduria is a predictor for candidaemia; however, patient characteristics that are associated with concurrent candidaemia in the setting of candiduria are unclear. Identifying these characteristics could aid in the early detection of systemic disease. We performed a retrospective cohort analysis of hospitalised patients with candiduria at our institution over a 13-year period. Our evaluation of patient characteristics included demographics, comorbidities, medications, procedures, devices, vital signs and laboratory values. We developed a multivariable logistic model to identify factors associated with candidaemia in patients with candiduria. We identified 4240 patients with candiduria, 263 (6.2%) of whom had candidaemia. Predictors for increased risk of candidaemia with candiduria included hospitalisations > 12 days, central venous catheter, parenteral nutrition, haematological and gynaecological malignancy, and receipt of β-lactam/β-lactamase inhibitors. Vital signs and laboratory values associated with candidaemia included elevated heart rate, temperature and creatinine, along with neutropenia and neutrophilia. Factors that demonstrated a decreased risk of candidaemia included diabetes mellitus, gastrostomy and urinary catheter with antibiotic use. The c-statistic was 0.741 (95% CI, 0.710-0.772). We identified a set of clinical characteristics that can predict the presence of candidaemia with candiduria.
AB - Candidaemia is the most common clinical presentation of invasive candidiasis and is a major cause of morbidity and mortality. Candiduria is a predictor for candidaemia; however, patient characteristics that are associated with concurrent candidaemia in the setting of candiduria are unclear. Identifying these characteristics could aid in the early detection of systemic disease. We performed a retrospective cohort analysis of hospitalised patients with candiduria at our institution over a 13-year period. Our evaluation of patient characteristics included demographics, comorbidities, medications, procedures, devices, vital signs and laboratory values. We developed a multivariable logistic model to identify factors associated with candidaemia in patients with candiduria. We identified 4240 patients with candiduria, 263 (6.2%) of whom had candidaemia. Predictors for increased risk of candidaemia with candiduria included hospitalisations > 12 days, central venous catheter, parenteral nutrition, haematological and gynaecological malignancy, and receipt of β-lactam/β-lactamase inhibitors. Vital signs and laboratory values associated with candidaemia included elevated heart rate, temperature and creatinine, along with neutropenia and neutrophilia. Factors that demonstrated a decreased risk of candidaemia included diabetes mellitus, gastrostomy and urinary catheter with antibiotic use. The c-statistic was 0.741 (95% CI, 0.710-0.772). We identified a set of clinical characteristics that can predict the presence of candidaemia with candiduria.
KW - Candida spp
KW - candidemia
KW - candiduria
KW - clinical prediction model
KW - colonisation
KW - protective factors
KW - risk factors
KW - systemic infection
UR - http://www.scopus.com/inward/record.url?scp=85066836372&partnerID=8YFLogxK
U2 - 10.1111/myc.12917
DO - 10.1111/myc.12917
M3 - Article
C2 - 31025417
AN - SCOPUS:85066836372
SN - 0933-7407
VL - 62
SP - 554
EP - 561
JO - Mycoses
JF - Mycoses
IS - 7
ER -